Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment

Background and objective Lung cancer still has the highest incidence rate and mortality rate nowadays. In recent years, with the emergence of new drugs and the optimization of treatment mode, especially the clinical application of immunotherapy, the prognosis of lung cancer patients has been improve...

Full description

Bibliographic Details
Main Authors: Shikang ZHAO, Xin JIN, Song XU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.105.01
_version_ 1818439329156956160
author Shikang ZHAO
Xin JIN
Song XU
author_facet Shikang ZHAO
Xin JIN
Song XU
author_sort Shikang ZHAO
collection DOAJ
description Background and objective Lung cancer still has the highest incidence rate and mortality rate nowadays. In recent years, with the emergence of new drugs and the optimization of treatment mode, especially the clinical application of immunotherapy, the prognosis of lung cancer patients has been improved. However, the benefits of immunotherapy are still limited. Therefore, it is necessary to find new biomarkers to predict the prognosis of lung adenocarcinoma patients and explore its impact on the immune microenvironment. Methods The Cancer Genome Atlas (TCGA) database was used to analyze the gene sequencing and clinical data of patients with lung adenocarcinoma. The distribution of RASGRP2 in lung adenocarcinoma was determined by using the human protein mapping database. The Kaplan-Meier plotter database was used to explore the relationship between the expression of RASGRP2 and the prognosis of patients with lung adenocarcinoma. KEGG and GO gene enrichment analysis was performed in patients with high and low expression of RASGRP2. TCGA database was used to analyze the co-expression genes of RASGRP2 and TIMER database was used to calculate the immune related lymphoid infiltration of RASGRP2 and its coexpression genes. The relationship between RASGRP2 expression and immune checkpoint expression was analyzed by using TIMER 2.0 database. Results We found that RASGRP2 was low expressed in lung adenocarcinoma, and its expression level was related to the prognosis of patients. The high expression of RASGRP2 was involved in the process of hematopoietic cell formation and cell adhesion, and RASGRP2 played an important role in the process of T cell activation. Through TCGA database analysis, ZAP70, TBC1D10C, RASAL3, FGD2, CD37 and ACAP1 were significantly correlated with RASGRP2. The high expression of these genes leaded to the increase of the proportion of CD8+ T cells, memory CD4+ T cells, and the decrease of the proportion of neutrophils and Treg cells. Finally, we found that the expression of RASGRP2 was significantly correlated with the expression of CD274, CTLA4, LAG3 and TIGIT. Conclusion RASGRP2 was abnormally expressed in lung adenocarcinoma and correlated with the infiltration level of immune related cells, which might influence the efficacy of immunotherapy.
first_indexed 2024-12-14T17:54:44Z
format Article
id doaj.art-73cdb4e976af4f678e4e70232bddf20f
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-14T17:54:44Z
publishDate 2021-06-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-73cdb4e976af4f678e4e70232bddf20f2022-12-21T22:52:34ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872021-06-0124640441110.3779/j.issn.1009-3419.2021.105.01Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune MicroenvironmentShikang ZHAO0Xin JIN1Song XU2Department of Lung Cancer Surgery; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Lung Cancer Surgery; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, ChinaDepartment of Lung Cancer Surgery; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin 300052, ChinaBackground and objective Lung cancer still has the highest incidence rate and mortality rate nowadays. In recent years, with the emergence of new drugs and the optimization of treatment mode, especially the clinical application of immunotherapy, the prognosis of lung cancer patients has been improved. However, the benefits of immunotherapy are still limited. Therefore, it is necessary to find new biomarkers to predict the prognosis of lung adenocarcinoma patients and explore its impact on the immune microenvironment. Methods The Cancer Genome Atlas (TCGA) database was used to analyze the gene sequencing and clinical data of patients with lung adenocarcinoma. The distribution of RASGRP2 in lung adenocarcinoma was determined by using the human protein mapping database. The Kaplan-Meier plotter database was used to explore the relationship between the expression of RASGRP2 and the prognosis of patients with lung adenocarcinoma. KEGG and GO gene enrichment analysis was performed in patients with high and low expression of RASGRP2. TCGA database was used to analyze the co-expression genes of RASGRP2 and TIMER database was used to calculate the immune related lymphoid infiltration of RASGRP2 and its coexpression genes. The relationship between RASGRP2 expression and immune checkpoint expression was analyzed by using TIMER 2.0 database. Results We found that RASGRP2 was low expressed in lung adenocarcinoma, and its expression level was related to the prognosis of patients. The high expression of RASGRP2 was involved in the process of hematopoietic cell formation and cell adhesion, and RASGRP2 played an important role in the process of T cell activation. Through TCGA database analysis, ZAP70, TBC1D10C, RASAL3, FGD2, CD37 and ACAP1 were significantly correlated with RASGRP2. The high expression of these genes leaded to the increase of the proportion of CD8+ T cells, memory CD4+ T cells, and the decrease of the proportion of neutrophils and Treg cells. Finally, we found that the expression of RASGRP2 was significantly correlated with the expression of CD274, CTLA4, LAG3 and TIGIT. Conclusion RASGRP2 was abnormally expressed in lung adenocarcinoma and correlated with the infiltration level of immune related cells, which might influence the efficacy of immunotherapy.http://dx.doi.org/10.3779/j.issn.1009-3419.2021.105.01lung adenocarcinomaimmunotherapyrasgrp2prognosisimmune microenvironment
spellingShingle Shikang ZHAO
Xin JIN
Song XU
Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
Chinese Journal of Lung Cancer
lung adenocarcinoma
immunotherapy
rasgrp2
prognosis
immune microenvironment
title Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
title_full Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
title_fullStr Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
title_full_unstemmed Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
title_short Expression of RASGRP2 in Lung Adenocarcinoma and Its Effect 
on Immune Microenvironment
title_sort expression of rasgrp2 in lung adenocarcinoma and its effect 
on immune microenvironment
topic lung adenocarcinoma
immunotherapy
rasgrp2
prognosis
immune microenvironment
url http://dx.doi.org/10.3779/j.issn.1009-3419.2021.105.01
work_keys_str_mv AT shikangzhao expressionofrasgrp2inlungadenocarcinomaanditseffectonimmunemicroenvironment
AT xinjin expressionofrasgrp2inlungadenocarcinomaanditseffectonimmunemicroenvironment
AT songxu expressionofrasgrp2inlungadenocarcinomaanditseffectonimmunemicroenvironment